UiPath (NYSE:PATH) Trading Up 3.7%

UiPath Inc. (NYSE:PATH - Get Free Report)'s stock price rose 3.7% on Tuesday . The stock traded as high as $19.61 and last traded at $19.58. Approximately 1,739,844 shares changed hands during trading, a decline of 80% from the average daily volume of 8,776,809 shares. The stock had previously closed at $18.89.

Analyst Ratings Changes

PATH has been the subject of several analyst reports. Canaccord Genuity Group raised their price target on UiPath from $27.00 to $30.00 and gave the company a "buy" rating in a report on Friday, March 15th. TD Cowen upped their price objective on UiPath from $25.00 to $28.00 and gave the company an "outperform" rating in a research report on Thursday, March 14th. William Blair initiated coverage on UiPath in a research report on Tuesday, January 2nd. They issued an "outperform" rating on the stock. Wells Fargo & Company upped their price target on shares of UiPath from $24.00 to $25.00 and gave the company an "equal weight" rating in a research report on Thursday, March 14th. Finally, Mizuho raised their price objective on shares of UiPath from $22.00 to $25.00 and gave the stock a "neutral" rating in a report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $27.41.

UiPath Trading Up 3.4 %

The firm has a 50 day moving average of $22.55 and a 200-day moving average of $21.56. The company has a market cap of $11.12 billion, a P/E ratio of -114.93 and a beta of 0.96.

UiPath (NYSE:PATH - Get Free Report) last issued its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping analysts' consensus estimates of ($0.04) by $0.10. The firm had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Equities analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Activity

In other news, CFO Ashim Gupta sold 40,000 shares of the firm's stock in a transaction that occurred on Thursday, April 4th. The stock was sold at an average price of $21.66, for a total value of $866,400.00. Following the completion of the sale, the chief financial officer now directly owns 660,762 shares of the company's stock, valued at approximately $14,312,104.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 72,000 shares of company stock valued at $1,591,360 in the last ninety days. Insiders own 31.03% of the company's stock.

Institutional Investors Weigh In On UiPath

Institutional investors have recently modified their holdings of the stock. Royal London Asset Management Ltd. lifted its stake in shares of UiPath by 5.9% during the 3rd quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company's stock worth $2,388,000 after acquiring an additional 7,742 shares during the last quarter. O Shaughnessy Asset Management LLC bought a new stake in UiPath during the 3rd quarter valued at $203,000. Invesco Ltd. raised its position in UiPath by 2.8% during the 3rd quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company's stock valued at $6,830,000 after purchasing an additional 10,863 shares in the last quarter. Symmetry Partners LLC bought a new stake in UiPath during the 4th quarter valued at $205,000. Finally, Toroso Investments LLC raised its position in UiPath by 196.7% during the 3rd quarter. Toroso Investments LLC now owns 78,189 shares of the healthcare company's stock valued at $1,338,000 after purchasing an additional 51,834 shares in the last quarter. 62.50% of the stock is owned by institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.